Labcorp Holdings Long-Term Investments 2010-2025 | LH
Labcorp Holdings long-term investments from 2010 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Labcorp Holdings long-term investments for the quarter ending March 31, 2025 were $168M, a 849.15% increase year-over-year.
- Labcorp Holdings long-term investments for 2024 were $0.016B, a 39.41% decline from 2023.
- Labcorp Holdings long-term investments for 2023 were $0.027B, a 59.06% decline from 2022.
- Labcorp Holdings long-term investments for 2022 were $0.066B, a 7.88% increase from 2021.
| Labcorp Holdings Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $16 |
| 2023 | $27 |
| 2022 | $66 |
| 2021 | $61 |
| 2020 | $74 |
| 2019 | $85 |
| 2018 | $61 |
| 2017 | $58 |
| 2016 | $58 |
| 2015 | $58 |
| 2014 | $93 |
| 2013 | $89 |
| 2012 | $78 |
| 2011 | $77 |
| 2010 | $79 |
| 2009 | $71 |
| Labcorp Holdings Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2025-03-31 | $168 |
| 2024-12-31 | $16 |
| 2024-09-30 | $17 |
| 2024-06-30 | $18 |
| 2024-03-31 | $18 |
| 2023-12-31 | $27 |
| 2023-09-30 | $40 |
| 2023-06-30 | $67 |
| 2023-03-31 | $66 |
| 2022-12-31 | $66 |
| 2022-09-30 | $64 |
| 2022-06-30 | $58 |
| 2022-03-31 | $62 |
| 2021-12-31 | $61 |
| 2021-09-30 | $62 |
| 2021-06-30 | $82 |
| 2021-03-31 | $85 |
| 2020-12-31 | $74 |
| 2020-09-30 | $71 |
| 2020-06-30 | $72 |
| 2020-03-31 | $67 |
| 2019-12-31 | $85 |
| 2019-09-30 | $86 |
| 2019-06-30 | $87 |
| 2019-03-31 | $67 |
| 2018-12-31 | $61 |
| 2018-09-30 | $58 |
| 2018-06-30 | $59 |
| 2018-03-31 | $58 |
| 2017-12-31 | $58 |
| 2017-09-30 | $65 |
| 2017-06-30 | $67 |
| 2017-03-31 | $58 |
| 2016-12-31 | $58 |
| 2016-09-30 | $60 |
| 2016-06-30 | $62 |
| 2016-03-31 | $61 |
| 2015-12-31 | $58 |
| 2015-09-30 | $62 |
| 2015-06-30 | $69 |
| 2015-03-31 | $89 |
| 2014-12-31 | $93 |
| 2014-09-30 | $95 |
| 2014-06-30 | $97 |
| 2014-03-31 | $87 |
| 2013-12-31 | $89 |
| 2013-09-30 | $87 |
| 2013-06-30 | $88 |
| 2013-03-31 | $87 |
| 2012-12-31 | $78 |
| 2012-09-30 | $81 |
| 2012-06-30 | $79 |
| 2012-03-31 | $80 |
| 2011-12-31 | $77 |
| 2011-09-30 | $75 |
| 2011-06-30 | $79 |
| 2011-03-31 | $83 |
| 2010-12-31 | $79 |
| 2010-09-30 | $80 |
| 2010-06-30 | $71 |
| 2010-03-31 | $69 |
| 2009-12-31 | $71 |
| 2009-09-30 | $75 |
| 2009-06-30 | $69 |
| 2009-03-31 | $64 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $21.509B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.179B | 27.04 |
| CVS Health (CVS) | United States | $86.198B | 10.71 |
| Elevance Health (ELV) | United States | $84.314B | 10.88 |
| Cencora (COR) | United States | $57.484B | 20.00 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.963B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.205B | 0.00 |
| Solventum (SOLV) | United States | $12.912B | 13.67 |
| CochLear (CHEOY) | Australia | $12.870B | 0.00 |
| ICON (ICLR) | Ireland | $11.851B | 11.02 |
| Revvity (RVTY) | United States | $11.644B | 20.04 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Avantor (AVTR) | United States | $9.363B | 13.60 |
| HealthEquity (HQY) | United States | $9.068B | 39.72 |
| Medpace Holdings (MEDP) | United States | $8.818B | 23.42 |
| Sonic Healthcare (SKHHY) | Australia | $8.465B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.445B | 14.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.269B | 25.15 |
| BrightSpring Health Services (BTSG) | United States | $4.058B | 37.23 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.781B | 36.17 |
| Alignment Healthcare (ALHC) | United States | $2.722B | 0.00 |
| Concentras Parent (CON) | United States | $2.652B | 15.33 |
| Organon (OGN) | United States | $2.594B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.556B | 98.45 |
| PACS (PACS) | United States | $1.958B | 0.00 |
| Ardent Health (ARDT) | United States | $1.904B | 8.12 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.796B | 13.63 |
| GoodRx Holdings (GDRX) | United States | $1.761B | 35.21 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.181B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| CareDx (CDNA) | United States | $1.074B | 16.77 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| LifeMD (LFMD) | United States | $0.615B | 0.00 |
| Embecta (EMBC) | United States | $0.542B | 3.65 |
| InnovAge Holding (INNV) | United States | $0.532B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| Omada Health (OMDA) | $0.460B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.312B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.249B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| So-Young (SY) | China | $0.209B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.096B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.051B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |